Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TOVIAZ safely and effectively. See full prescribing information for TOVIAZ. TOVIAZ® (fesoterodine fumarate) extended-release tablets, for oral useInitial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
Toviaz is indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. Toviaz is indicated for the treatment of neurogenic detrusor overactivity (NDO) in pediatric patients 6 years of age and older with a body weight greater than 25 kg.
- generic_name
- fesoterodine fumarate
- product_names
- fesoterodine fumarate
- ndc
- 0069-0242, 0069-0244, 0069-0242-30, 0069-0244-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en